We are live on ! Find out more
AV

ASR Vermogensbeheer Portfolio holdings

AUM $8.5B
1-Year Est. Return 25.14%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+25.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.5B
AUM Growth
-$96.1M
Cap. Flow
+$411M
Cap. Flow %
4.83%
Top 10 Hldgs %
34.38%
Holding
534
New
8
Increased
456
Reduced
39
Closed
2

Top Buys

1
AZN icon
AstraZeneca
AZN
+$162M
2
SUNB
Sunbelt Rentals Holdings
SUNB
+$41.2M
3
NVDA icon
NVIDIA
NVDA
+$33.2M
4
UBS icon
UBS Group
UBS
+$19.4M
5
AAPL icon
Apple
AAPL
+$16.9M

Top Sells

1
META icon
Meta Platforms (Facebook)
META
+$17.1M
2
BDX icon
Becton Dickinson
BDX
+$8.94M
3
SLB icon
SLB Ltd
SLB
+$7.67M
4
GIB icon
CGI
GIB
+$4.75M
5
AMAT icon
Applied Materials
AMAT
+$3.24M

Sector Composition

1 Technology 30.92%
2 Financials 13.2%
3 Healthcare 11.8%
4 Consumer Discretionary 10.12%
5 Communication Services 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$198B
$50.9M 0.6%
103,533
+871
+0.8% +$473K
TT icon
27
Trane Technologies
TT
$104B
$50.5M 0.59%
121,169
+969
+0.8% +$411K
UBS icon
28
UBS Group
UBS
$173B
$50.4M 0.59%
1,317,110
+453,568
+53% +$19.4M
BKNG icon
29
Booking.com
BKNG
$141B
$49M 0.58%
291,075
+26,000
+10% +$4.78M
MA icon
30
Mastercard
MA
$480B
$48M 0.57%
96,154
+1,717
+2% +$904K
CB icon
31
Chubb
CB
$137B
$47.9M 0.56%
146,927
+3,561
+2% +$1.14M
ECL icon
32
Ecolab
ECL
$76.8B
$45.5M 0.53%
170,987
+1,199
+0.7% +$338K
ABBV icon
33
AbbVie
ABBV
$450B
$40.5M 0.48%
186,146
+3,284
+2% +$728K
CAT icon
34
Caterpillar
CAT
$405B
$40.1M 0.47%
56,575
+1,002
+2% +$694K
AMT icon
35
American Tower
AMT
$79.2B
$40.1M 0.47%
232,177
+6,663
+3% +$1.2M
KO icon
36
Coca-Cola
KO
$351B
$39.7M 0.47%
521,446
+10,348
+2% +$782K
ORLY icon
37
O'Reilly Automotive
ORLY
$71.3B
$39.6M 0.47%
429,157
+16,021
+4% +$1.5M
ACN icon
38
Accenture
ACN
$87.9B
$39.3M 0.46%
198,451
+5,585
+3% +$1.3M
MU icon
39
Micron Technology
MU
$959B
$39.1M 0.46%
115,747
+2,011
+2% +$788K
ADBE icon
40
Adobe
ADBE
$94.3B
$38.3M 0.45%
157,551
+13,751
+10% +$3.81M
PG icon
41
Procter & Gamble
PG
$349B
$38.2M 0.45%
264,717
+8,270
+3% +$1.25M
ICE icon
42
Intercontinental Exchange
ICE
$79B
$36.8M 0.43%
234,149
+6,737
+3% +$1.1M
SUNB
43
Sunbelt Rentals Holdings
SUNB
$30.1B
$36.7M 0.43%
+586,983
New +$41.2M
BAC icon
44
Bank of America
BAC
$430B
$36.3M 0.43%
744,937
+13,099
+2% +$676K
PPG icon
45
PPG Industries
PPG
$26.2B
$36.3M 0.43%
339,512
+1,810
+0.5% +$205K
PEG icon
46
Public Service Enterprise Group
PEG
$39.2B
$35.7M 0.42%
441,005
+10,581
+2% +$867K
DAR icon
47
Darling Ingredients
DAR
$10B
$34.8M 0.41%
563,122
+7,062
+1% +$348K
AJG icon
48
Arthur J. Gallagher & Co
AJG
$65.2B
$34.6M 0.41%
159,959
+14,958
+10% +$3.45M
AMD icon
49
Advanced Micro Devices
AMD
$808B
$34.6M 0.41%
170,304
+2,993
+2% +$639K
PLTR icon
50
Palantir
PLTR
$317B
$34.5M 0.41%
236,043
+4,060
+2% +$621K
1
2
3 4 5

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return

ASR Vermogensbeheer's Q1 2026 Portfolio in Review

As of Q1 2026, ASR Vermogensbeheer held 534 positions worth $8.5B, down 1.1% from $8.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ASR Vermogensbeheer deployed $411M of net new capital in Q1 2026, opening 8 new positions and adding to 456 existing holdings. Its largest new stake was AstraZeneca: 841,921 shares worth $163M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $17.1M trimmed.

  • ASR Vermogensbeheer's largest Q1 2026 buy was AstraZeneca: 841,921 shares worth $163M.
  • ASR Vermogensbeheer added most to NVIDIA in Q1 2026, an estimated $33.2M increase.
  • ASR Vermogensbeheer's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $17.1M.
  • ASR Vermogensbeheer fully exited Amrize Ltd in Q1 2026, selling an estimated $1.58M.
  • ASR Vermogensbeheer's ten largest holdings make up 34% of its $8.5B portfolio in Q1 2026.
  • ASR Vermogensbeheer opened 8 new positions and closed 2 in Q1 2026.
  • ASR Vermogensbeheer's portfolio value fell 1.1% quarter-over-quarter to $8.5B.

Based on ASR Vermogensbeheer's 13F filing for Q1 2026, filed 30 Apr 2026.